Published in Eur J Nutr on January 18, 2015
Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med (2008) 57.29
Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med (1996) 46.18
Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care (2003) 29.49
General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation (2008) 26.42
Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation. JAMA (2001) 17.91
Diagnostic tests 2: Predictive values. BMJ (1994) 12.97
Limitations of the odds ratio in gauging the performance of a diagnostic, prognostic, or screening marker. Am J Epidemiol (2004) 12.03
What do we mean by validating a prognostic model? Stat Med (2000) 9.18
Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association. Circulation (2009) 8.11
A better index of body adiposity. Obesity (Silver Spring) (2011) 7.53
Prognosis and prognostic research: validating a prognostic model. BMJ (2009) 6.54
Accuracy of body mass index in diagnosing obesity in the adult general population. Int J Obes (Lond) (2008) 5.03
Waist-to-height ratio is a better screening tool than waist circumference and BMI for adult cardiometabolic risk factors: systematic review and meta-analysis. Obes Rev (2011) 4.07
Statistical methods for assessment of added usefulness of new biomarkers. Clin Chem Lab Med (2010) 3.57
Six reasons why the waist-to-height ratio is a rapid and effective global indicator for health risks of obesity and how its use could simplify the international public health message on obesity. Int J Food Sci Nutr (2005) 3.21
The predictive value of different measures of obesity for incident cardiovascular events and mortality. J Clin Endocrinol Metab (2010) 3.12
Prevention of non-communicable disease in a population in nutrition transition: Tehran Lipid and Glucose Study phase II. Trials (2009) 2.92
Combining body mass index with measures of central obesity in the assessment of mortality in subjects with coronary disease: role of "normal weight central obesity". J Am Coll Cardiol (2013) 2.61
Visceral Adiposity Index: a reliable indicator of visceral fat function associated with cardiometabolic risk. Diabetes Care (2010) 2.44
Measuring adiposity in patients: the utility of body mass index (BMI), percent body fat, and leptin. PLoS One (2012) 2.12
Body shape index and mortality in hemodialysis patients. Nutrition (2013) 2.06
Novel metrics for evaluating improvement in discrimination: net reclassification and integrated discrimination improvement for normal variables and nested models. Stat Med (2011) 2.03
An interpretation for the ROC curve and inference using GLM procedures. Biometrics (2000) 2.01
A new body shape index predicts mortality hazard independently of body mass index. PLoS One (2012) 1.94
Which measures of obesity best predict cardiovascular risk? J Am Coll Cardiol (2008) 1.94
Problems with risk reclassification methods for evaluating prediction models. Am J Epidemiol (2011) 1.84
Utility of waist-to-height ratio in assessing the status of central obesity and related cardiometabolic risk profile among normal weight and overweight/obese children: the Bogalusa Heart Study. BMC Pediatr (2010) 1.72
Prevalence of sarcopenia and sarcopenic obesity in Korean adults: the Korean sarcopenic obesity study. Int J Obes (Lond) (2009) 1.65
Does body mass index adequately convey a patient's mortality risk? JAMA (2013) 1.54
Sarcopenia, sarcopenic obesity and mortality in older adults: results from the National Health and Nutrition Examination Survey III. Eur J Clin Nutr (2014) 1.44
Sarcopenia definitions considering body size and fat mass are associated with mobility limitations: the Framingham Study. J Gerontol A Biol Sci Med Sci (2012) 1.39
Waist Circumference, Body Mass Index, and Other Measures of Adiposity in Predicting Cardiovascular Disease Risk Factors among Peruvian Adults. Int J Hypertens (2011) 1.34
Obesity: criteria and classification. Proc Nutr Soc (2000) 1.32
Validation of bioelectrical impedance analysis in adolescents across different ethnic groups. Obesity (Silver Spring) (2009) 1.31
Anthropometric measures, body composition, body fat distribution, and knee osteoarthritis in women. Obesity (Silver Spring) (2006) 1.30
Adult socioeconomic position and the association between height and coronary heart disease mortality: findings from 33 years of follow-up in the Whitehall Study. Am J Public Health (2005) 1.18
Could the new body shape index predict the new onset of diabetes mellitus in the Chinese population? PLoS One (2013) 1.10
Prognostic significance of the complex "Visceral Adiposity Index" vs. simple anthropometric measures: Tehran lipid and glucose study. Cardiovasc Diabetol (2012) 1.04
Reduction in incidence of type 2 diabetes by lifestyle intervention in a middle eastern community. Am J Prev Med (2010) 1.04
"A Body Shape Index" in middle-age and older Indonesian population: scaling exponents and association with incident hypertension. PLoS One (2014) 1.03
Association of total cholesterol versus other serum lipid parameters with the short-term prediction of cardiovascular outcomes: Tehran Lipid and Glucose Study. Eur J Cardiovasc Prev Rehabil (2006) 1.01
Waist-to-height ratio and cardiovascular risk factors in elderly individuals at high cardiovascular risk. PLoS One (2012) 1.00
Assessing body shape index as a risk predictor for cardiovascular diseases and metabolic syndrome among Iranian adults. Nutrition (2013) 0.97
Associations between body mass index, waist circumference and body shape index with resting blood pressure in Portuguese adolescents. Ann Hum Biol (2013) 0.96
Predictive accuracy of the 'Framingham's general CVD algorithm' in a Middle Eastern population: Tehran Lipid and Glucose Study. Int J Clin Pract (2011) 0.92
Pencina et al. respond to "The incremental value of new markers" and "Clinically relevant measures? A note of caution". Am J Epidemiol (2012) 0.91
Invited commentary: Clinical usefulness of the Framingham cardiovascular risk profile beyond its statistical performance. Am J Epidemiol (2012) 0.91
Measures of adiposity and cardiovascular disease risk factors, New York City Health and Nutrition Examination Survey, 2004. Prev Chronic Dis (2011) 0.88
Reduction in adiposity, β-cell function, insulin sensitivity, and cardiovascular risk factors: a prospective study among Japanese with obesity. PLoS One (2013) 0.82
Defining body fatness in adolescents: a proposal of the AFAD-A classification. PLoS One (2013) 0.82
Inverse relationship between "a body shape index" (ABSI) and fat-free mass in women and men: Insights into mechanisms of sarcopenic obesity. Clin Nutr (2014) 0.81
Thoroughly modern risk prediction? Sci Transl Med (2012) 0.80
Evaluation of cause of deaths' validity using outcome measures from a prospective, population based cohort study in Tehran, Iran. PLoS One (2012) 0.80
Association between different obesity measures and the risk of stroke in the EPIC Spanish cohort. Eur J Nutr (2014) 0.80
A body shape index has a good correlation with postoperative complications in gastric cancer surgery. Ann Surg Oncol (2013) 0.77